Name: enGene Holdings Inc. (ENGN) Financial Statements
Creator: FinSpry

enGene Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

enGene Holdings Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.51	0.00	0.00	0.00	0.00
Gross Profit	-0.51	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	94.48	38.32	16.46	15.47	12.46
Selling, General & Administrative	28.69	23.98	9.60	3.96	3.41
Operating Expenses	123.17	62.30	26.06	19.43	15.87
Operating Income	-123.17	-62.30	-26.06	-19.43	-15.87
Other Income/Expense
Interest Income	9.43	10.41	1.12	0.13	0.03
Interest Expense	2.99	2.80	-4.95	-1.42	-5.02
Other Income/Expense	5.86	-0.48	-10.57	-3.02	-4.20
Income
Income Before Tax	-117.30	-55.16	-99.90	-24.44	-23.44
Income Tax Expense	0.00	-0.02	0.02	0.02	0.00
Net Income	117.30	-55.14	-99.92	-24.46	-23.44
Net Income - Continuous Operations	117.30	-55.14	-99.92	-24.46	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-113.80	-52.04	-25.89	-19.19	-15.60
EBIT	-114.31	-52.36	-26.06	-19.43	-15.87
Depreciation & Amortization	0.51	0.32	0.18	0.24	0.27
Earnings Per Share
Basic EPS	-2.00	-1.00	-151.00	-44.00	-6.00
Diluted EPS	-2.00	-1.00	-151.00	-44.00	-6.00
Basic Shares Outstanding	51.12	37.78	0.69	0.66	3.56
Diluted Shares Outstanding	51.12	37.78	0.69	0.66	3.56